Marapharm Ventures (CSE:MDM) has announced that steps are underway to create a cannabis campus with facilities on its property.
Linda Sampson, CEO of Marapharm, said:

Future plans could include a research and development laboratory, cultivation, ancillary products and processing. One existing building is presently being used for a tier 3 cannabis cultivator, licensed for up to 30,000 square feet of cultivation space. Currently, there are operations in only a 1500 square foot section of the building, while the remainder of the building is being prepared to undergo extensive renovations. The smaller space includes room for mothers, clones, vegetation, cultivation, drying, curing and processing, and also allows the license holder to produce approximately $50,000 US per harvest and 4 harvests have been produced since September 2016. This smaller space has enabled them to generate revenue in order to partially pay lease payments while training staff and developing specific strains to bring to market. The harvests are pre-sold to dispensaries and retailers are patiently waiting for the new strains and products that will be produced in the completed 30,000 square foot facility. Construction can finally get underway, because we now own the property and we anticipate the renovations to be completed on or before May 30, 2017. Once construction is complete in the main area, the remainder of the building will undergo the same upgrades.
The license holder also has an unlimited square footage processing license. Marapharm has a 9.000 square foot building alongside the cultivation center to be used as a processing facility. Applications for permits and regulatory approvals are underway. The facility will have Vitalis CO2 extraction equipment, a packaging center and a kitchen for edibles. The extraction equipment is designed to extract oil while maintaining the valuable terpene profile of each strain, and has a 90L capacity. The double chambers allow the equipment to operate without a down time during processing cycles. A menu of pre-approved edibles will be produced in the fully-equipped industrial kitchen. This turnkey designed facility will be a signature and highly functional space and is projected to produce revenues for the license holders of more than $2 million each month.

Click here to read the full press release.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less